Urinary excretion of equol by postmenopausal women consuming soymilk fermented by probiotic bifidobacteria

European Journal of Clinical Nutrition

Volumn 61, Issue 3, 2007, Pages 438-441

  Tsangalis, D ^a   Wilcox, G ^b   Shah, N P ^a   McGill, A E J ^a   Stojanovska, L ^b  

^a MONASH UNIVERSITY   (Australia)

^b VICTORIA UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGLYCONE; CARBOHYDRATE; DAIDZEIN; EQUOL; GLUCOSIDE; ISOFLAVONE; PROBIOTIC AGENT;

ADULT; ARTICLE; AUSTRALIA; BIFIDOBACTERIUM; CARBOHYDRATE INTAKE; CONTROLLED STUDY; DIET; FEMALE; FERMENTATION; FOOD INTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PILOT STUDY; POSTMENOPAUSE; RANDOMIZATION; SOYBEAN MILK; URINARY EXCRETION;

BIFIDOBACTERIUM; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FERMENTATION; FOOD HANDLING; HUMANS; ISOFLAVONES; MIDDLE AGED; PHYTOESTROGENS; PILOT PROJECTS; POSTMENOPAUSE; PROBIOTICS; SOY MILK;

EID: 33847621617     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1602530     Document Type: Article

References (12)

1. Akaza H, Miyanaga N, Takashima N, Naito S, Hirao Y, Tsukamoto T et al. (2004). Comparisons of percent equol producers between prostate cancer patients and controls: Case-controlled studies of isoflavones in Japanese, Korean and American residents. Jpn J Clin Oncol 34, 86-89.
2. Arora A, Nair MG, Strasburg GM (1998). Antioxidant activities of isoflavones and their biological metabolites in a liposomal system. Arch Biochem Biophys 356, 133-141.
3. Ballongue J (1993). Bifidobacteria and probiotic action. In: Salminen S, Von Wright A (eds). Lactic Acid Bacteria. Marcel Dekker: New York. pp 519-587.
4. Lu L-JW, Anderson KE (1998). Sex and long-term soy diets affect the metabolism and excretion of soy isoflavones in humans. Am J Clin Nutr 68, 1500S-1504S.
5. Morito K, Hirose T, Kinjo J, Hirakawa T, Ckawa M, Nohara T et al. (2001). Interaction of phytoestrogens with estrogen receptors α and β. Biol Pharm Bull 24, 351-356.
6. Orrhage K, Nord CE (2000). Bifidobacteria and lactobacilli in human health. Drugs Exp Clin Res 26, 95-111.
7. Rowland IR, Wiseman H, Sanders TAB, Adlercreutz H, Bowey EA (2000). Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer 36, 27-32.
8. Setchell KDR, Brown N, Lydeking-Olsen E (2002). The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 132, 3577-3584.
9. Setchell KDR, Maynard-Brown N, Desai PB, Zimmer-Nechemias L, Wolfe B, Jakate AS et al. (2003). Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J Nutr 133, 1027-1035.
10. Tsangalis D, Ashton JF, McGill AEJ, Shah NP (2002). Enzymic transformation of isoflavone phytoestrogens in soymilk by β-glucosidase-producing bifidobacteria. J Food Sci 67, 3104-3113.
11. Tsangalis D, Wilcox G, Shah NP, Stojanovska L (2005). Bioavailability of isoflavone phytoestrogens in postmenopausal women consuming soya milk fermented with probiotic bifidobacteria. Br J Nutr 93, 867-877.
12. Xu X, Wang H-J, Murphy PA, Cook L, Hendrich S (1994). Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr 124, 825-832.